A detailed history of Efg Asset Management (North America) Corp. transactions in Dexcom Inc stock. As of the latest transaction made, Efg Asset Management (North America) Corp. holds 39,205 shares of DXCM stock, worth $2.99 Million. This represents 0.45% of its overall portfolio holdings.

Number of Shares
39,205
Previous 31,805 23.27%
Holding current value
$2.99 Million
Previous $3.61 Million 27.15%
% of portfolio
0.45%
Previous 0.64%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$64.0 - $116.06 $473,600 - $858,844
7,400 Added 23.27%
39,205 $2.63 Million
Q2 2024

Jul 25, 2024

SELL
$110.31 - $140.45 $286,254 - $364,467
-2,595 Reduced 7.54%
31,805 $3.61 Million
Q1 2024

May 13, 2024

SELL
$114.22 - $140.1 $96,401 - $118,244
-844 Reduced 2.39%
34,400 $4.77 Million
Q4 2023

Feb 08, 2024

SELL
$75.49 - $124.16 $315,774 - $519,361
-4,183 Reduced 10.61%
35,244 $4.37 Million
Q3 2023

Nov 02, 2023

SELL
$86.06 - $137.93 $162,997 - $261,239
-1,894 Reduced 4.58%
39,427 $3.68 Million
Q2 2023

Jul 28, 2023

SELL
$112.47 - $130.98 $867,143 - $1.01 Million
-7,710 Reduced 15.72%
41,321 $5.31 Million
Q1 2023

Apr 27, 2023

SELL
$104.0 - $122.92 $1.11 Million - $1.32 Million
-10,720 Reduced 17.94%
49,031 $5.7 Million
Q4 2022

Feb 03, 2023

SELL
$84.98 - $122.67 $379,265 - $547,476
-4,463 Reduced 6.95%
59,751 $6.77 Million
Q3 2022

Oct 28, 2022

SELL
$76.35 - $94.18 $437,332 - $539,463
-5,728 Reduced 8.19%
64,214 $5.17 Million
Q2 2022

Aug 04, 2022

BUY
$67.99 - $132.89 $3.72 Million - $7.27 Million
54,674 Added 358.1%
69,942 $5.21 Million
Q1 2022

Apr 26, 2022

BUY
$94.08 - $130.2 $106,968 - $148,037
1,137 Added 8.05%
15,268 $7.81 Million
Q4 2021

Feb 18, 2022

BUY
$129.87 - $162.82 $1.84 Million - $2.3 Million
14,131 New
14,131 $7.59 Million

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $29.5B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Efg Asset Management (North America) Corp. Portfolio

Follow Efg Asset Management (North America) Corp. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Efg Asset Management (North America) Corp., based on Form 13F filings with the SEC.

News

Stay updated on Efg Asset Management (North America) Corp. with notifications on news.